查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498761

基于 PCR 的传染病市场，按疾病类型、应用、最终用户、技术、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

PCR-based Infectious Diseases Market, By Disease Type, By Application, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年基于PCR的传染病市场规模为47.9032亿美元，2024年至2032年复合年增长率为6.91%。

基于PCR的传染病市场-市场动态

采用基于 PCR 的 POCT 设备的趋势日益明显

基于 PCR 的 POCT 设备通常在几分钟内即可提供快速、准确的结果，从而实现快速诊断和及时干预。这在需要立即就患者护理做出决定的环境中尤其重要。许多基于 PCR 的 POCT 设备与数位健康技术集成，例如智慧型手机应用程式或基于云端的平台，从而实现即时资料分析、远端监控以及医疗保健提供者和患者之间的无缝通讯。据世界卫生组织（WHO）称，人类免疫缺陷病毒（HIV）是慢性传染病爱滋病的根源。世界卫生组织 (WHO) 对 2021 年的估计显示，全球有 65 万人死于爱滋病毒相关原因，全球仍有 3,840 万人携带该病毒。

基于 PCR 的传染病市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.91% 左右的复合年增长率成长

根据疾病类型细分，预计病毒性疾病将在 2023 年呈现最大市场份额

从应用细分来看，临床诊断是2023年的主导类型

根据最终用户细分，医院和诊所是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

基于 PCR 的传染病市场区隔分析：

全球基于 PCR 的传染病市场根据疾病类型、应用、最终用户、技术和地区进行细分。

根据最终用户，市场分为四类：医院和诊所、诊断实验室、研究机构以及製药和生物技术公司。医院是最大的最终使用者群体。进行PCR分子诊断等各种诊断测试的主要医疗机构是医院。在医院中，PCR 技术对于准确、迅速地识别多种疾病至关重要。需要快速、准确的诊断测试来为治疗和患者管理选择提供信息，这推动了医院对 PCR 分子诊断的需求。

市场根据应用分为两类：临床诊断、研究应用和流行病学研究。临床诊断是最大的部分。基于 PCR 的传染病检测对于检测和追踪各种病原体（例如细菌、病毒和真菌）至关重要。世界各地传染病的流行推动了基于 PCR 的传染病检测的需求，这些传染病包括呼吸道感染、性传染病以及与医疗保健相关的感染。

基于 PCR 的传染病市场 - 地理洞察

由于完善的医疗基础设施、高额医疗支出以及较早采用 PCR 等先进诊断技术，北美地区往往拥有重要的市场份额。美国和加拿大是这个市场的主要贡献者。不同州和省的监管框架和医疗保健政策可能有所不同，从而影响市场动态。例如，报销政策或监管批准的差异可能会影响基于 PCR 的诊断的采用和渗透。由于先进的医疗保健系统和传染病的高发病率，欧洲国家也拥有相当大的市场份额。德国、英国、法国和义大利等国家是基于 PCR 的传染病诊断的主要市场。

基于PCR的传染病市场-竞争格局：

该市场的特点是存在多个关键参与者，包括生物技术和诊断公司、学术研究机构和医疗保健组织。基于 PCR 的传染病领域的主要参与者包括 Abbott Laboratories、Takara Bio, Inc、Thermo Fisher Scientific、Qiagen NV、Roche Diagnostics 等。罗氏是基于 PCR 的诊断市场的主要参与者，为传染病提供广泛的基于 PCR 的检测，包括爱滋病毒、肝炎和呼吸道感染。 Thermo Fisher 提供广泛的基于 PCR 的产品和解决方案组合，用于传染病检测，包括 COVID-19、呼吸道感染和性传播感染的检测。 Qiagen 提供一系列用于传染病检测的基于 PCR 的检测和样本製备技术，包括呼吸道感染、胃肠道感染和性传播感染的检测。

最近的发展：

2022 年 9 月，西北大学的子公司 Minute Molecular Diagnostics 创建了一种针对 COVID-19 的快速聚合酶链反应 (PCR) 测试。研究人员正在使用 Minute Molecular 的 DASH 分析仪（一种小型便携式设备）来创建快速 PCR 测试，该设备可在大约 15 分钟内提供易于读取的结果。

2021 年 8 月，QIAGEN 和 GT Molecular 合作提出了基于 QIAcuity 数位 PCR 创新的完整 SARS-CoV-2 废水辨识解决方案。

目录

第 1 章：基于 PCR 的传染病市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 基于 PCR 的传染病市场片段（依疾病类型）
    • 基于 PCR 的传染病市场片段（依应用）
    • 最终用户基于 PCR 的传染病市场片段
    • 基于 PCR 的传染病市场片段（按技术）
    • 基于 PCR 的传染病市场片段（按国家/地区）
    • 按地区分類的基于 PCR 的传染病市场片段
  • 竞争洞察

第 3 章：基于 PCR 的传染病主要市场趋势

  • 基于 PCR 的传染病市场驱动因素
    • 市场驱动因素的影响分析
  • 基于 PCR 的传染病市场限制
    • 市场限制影响分析
  • 基于 PCR 的传染病市场机会
  • 基于PCR的传染病市场未来趋势

第 4 章：基于 PCR 的传染病产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基于 PCR 的传染病市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基于 PCR 的传染病市场格局

  • 基于 PCR 的传染病市占率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基于 PCR 的传染病市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 病毒性疾病
      • 爱滋病
      • 肝炎
      • 流感
    • 细菌性疾病
      • 结核
      • 抗甲氧西林金黄色葡萄球菌
    • 霉菌感染
      • 念珠菌病
    • 寄生虫感染
    • 其他的

第 8 章：基于 PCR 的传染病市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 临床诊断
    • 研究应用
    • 流行病学研究

第 9 章：基于 PCR 的传染病市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 诊断实验室
    • 研究机构
    • 製药与生物技术公司

第 10 章：基于 PCR 的传染病市场 - 按技术分类

  • 概述
    • 按应用分類的细分市场占有率分析
    • 传统PCR
    • 实时萤光定量PCR (qPCR)
    • 数位 PCR (dPCR)
    • 逆转录酶 PCR (RT-PCR)
    • 巢式PCR
    • 多重PCR

第 11 章：基于 PCR 的传染病市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基于 PCR 的传染病主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 北美市场规模和预测（按技术）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基于 PCR 的传染病主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 欧洲市场规模与预测（按技术）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基于 PCR 的传染病主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 亚太地区市场规模与预测（按技术）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基于 PCR 的传染病主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 拉丁美洲市场规模与预测（按技术）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲基于 PCR 的传染病主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 中东和非洲市场规模及预测（按技术）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 基于 PCR 的传染病产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Takara Bio, Inc
    • Thermo Fisher Scientific
    • Qiagen NV
    • Bio-Rad Laboratories, Inc
    • Roche Diagnostics
    • Cepheid
    • DiaSorin
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2930

REPORT HIGHLIGHT

PCR-based Infectious Diseases Market size was valued at USD 4,790.32 million in 2023, expanding at a CAGR of 6.91% from 2024 to 2032.

The PCR-based infectious diseases market refers to the segment of the healthcare industry focused on diagnostic techniques that utilize Polymerase Chain Reaction (PCR) technology to identify pathogens responsible for infectious diseases. PCR is a molecular biology technique used to amplify DNA segments, making it a powerful tool for detecting the presence of viruses, bacteria, fungi, and other pathogens in clinical samples. The market has been experiencing steady growth due to several factors, including the increasing incidence of infectious diseases, advancements in PCR technology, growing demand for rapid and accurate diagnostic techniques, and rising healthcare expenditure. There is a growing trend towards the adoption of PCR-based POCT devices, which enable rapid and decentralized testing, particularly in resource-limited settings and for outbreak management.

PCR-based Infectious Diseases Market- Market Dynamics

Increasing Trend Toward the Adoption of PCR-based POCT Devices

PCR-based POCT devices offer rapid and accurate results, often within minutes, allowing for quick diagnosis and timely intervention. This is especially crucial in settings where immediate decisions need to be made regarding patient care. Many PCR-based POCT devices are integrated with digital health technologies, such as smartphone apps or cloud-based platforms, enabling real-time data analysis, remote monitoring, and seamless communication between healthcare providers and patients. According to the World Health Organization (WHO), the human immunodeficiency virus (HIV) is the source of the chronic infectious illness AIDS. World Health Organization (WHO) estimates for 2021 show that 0.65 million individuals died from HIV-related causes and that 38.4 million people worldwide were still living with the virus.

PCR-based Infectious Diseases Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.91% over the forecast period (2024-2032)

Based on disease type segmentation, viral diseases were predicted to show maximum market share in the year 2023

Based on application segmentation, Clinical diagnostics was the leading type in 2023

Based on end-user segmentation, Hospitals & Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

PCR-based Infectious Diseases Market- Segmentation Analysis:

The Global PCR-based Infectious Diseases Market is segmented on the basis of Disease Type, Application, End User, Technology, and Region.

The market is divided into four categories based on end-users: Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Pharmaceutical & Biotechnology Companies. Hospitals make up the biggest end-user segment. The main healthcare facilities that conduct a variety of diagnostic tests, such as PCR molecular diagnostics, are hospitals. In hospitals, PCR technology is essential for the precise and prompt identification of a wide range of illnesses. The requirement for quick and accurate diagnostic tests to inform therapy and patient management choices is what drives the demand for PCR molecular diagnostics in hospitals.

The market is divided into two categories based on application: Clinical diagnostics, Research applications, and Epidemiological studies. Clinical diagnostics is the largest segment. PCR-based infectious disease testing is essential for detecting and tracking a wide range of pathogens, such as bacteria, viruses, and fungi. The need for PCR-based infectious disease testing is driven by the prevalence of infectious diseases, including respiratory infections, STDs, and infections linked to healthcare, around the world.

PCR-based Infectious Diseases Market- Geographical Insights

North America region tends to have a significant market share due to well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced diagnostic technologies like PCR. The United States and Canada are key contributors to this market. Regulatory frameworks and healthcare policies can vary between different states and provinces, influencing market dynamics. For example, differences in reimbursement policies or regulatory approvals can impact the adoption and penetration of PCR-based diagnostics. Countries in Europe also have a considerable market share owing to advanced healthcare systems and a high prevalence of infectious diseases. Countries like Germany, the UK, France, and Italy are major markets for PCR-based infectious disease diagnostics.

PCR-based Infectious Diseases Market- Competitive Landscape:

The market is characterized by the presence of several key players, including biotechnology and diagnostic companies, academic research institutions, and healthcare organizations. Major players in PCR-based Infectious Diseases include Abbott Laboratories, Takara Bio, Inc, Thermo Fisher Scientific, Qiagen N.V., Roche Diagnostics etc. These players compete through product innovation, strategic collaborations, and geographical expansion. Roche is a major player in the PCR-based diagnostics market, offering a wide range of PCR-based tests for infectious diseases, including HIV, hepatitis, and respiratory infections. Thermo Fisher provides a broad portfolio of PCR-based products and solutions for infectious disease testing, including assays for COVID-19, respiratory infections, and sexually transmitted infections. Qiagen offers a range of PCR-based assays and sample preparation technologies for infectious disease testing, including tests for respiratory infections, gastrointestinal infections, and sexually transmitted infections.

Recent Developments:

In September 2022, Minute Molecular Diagnostics, a Northwestern University spinoff created a quick polymerase chain reaction (PCR) test for COVID-19. The researchers are employing Minute Molecular's DASH Analyzer, a small, portable device that offers easy-to-read results in around 15 minutes, to create a quick PCR test.

In August 2021, QIAGEN and GT Molecular collaborated to proposal a complete SARS-CoV-2 wastewater recognition resolution based on QIAcuity Digital PCR innovation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Takara Bio, Inc

Thermo Fisher Scientific

Qiagen N.V.

Bio-Rad Laboratories, Inc

Roche Diagnostics

Cepheid

DiaSorin

Others

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Viral diseases
  • HIV
  • hepatitis
  • influenza
  • Bacterial diseases
  • tuberculosis
  • MRSA
  • Fungal infections
  • candidiasis
  • Parasitic infections
  • Others

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical diagnostics
  • Research applications
  • Epidemiological studies

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Traditional PCR
  • Real-time PCR (qPCR)
  • Digital PCR (dPCR)
  • Reverse Transcriptase PCR (RT-PCR)
  • Nested PCR
  • Multiplex PCR

GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PCR-based Infectious Diseases Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PCR-based Infectious Diseases Market Snippet by Disease Type
    • 2.1.2. PCR-based Infectious Diseases Market Snippet by Application
    • 2.1.3. PCR-based Infectious Diseases Market Snippet by End User
    • 2.1.4. PCR-based Infectious Diseases Market Snippet by Technology
    • 2.1.5. PCR-based Infectious Diseases Market Snippet by Country
    • 2.1.6. PCR-based Infectious Diseases Market Snippet by Region
  • 2.2. Competitive Insights

3. PCR-based Infectious Diseases Key Market Trends

  • 3.1. PCR-based Infectious Diseases Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PCR-based Infectious Diseases Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PCR-based Infectious Diseases Market Opportunities
  • 3.4. PCR-based Infectious Diseases Market Future Trends

4. PCR-based Infectious Diseases Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PCR-based Infectious Diseases Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PCR-based Infectious Diseases Market Landscape

  • 6.1. PCR-based Infectious Diseases Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PCR-based Infectious Diseases Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 7.1.2. Viral diseases
      • 7.1.2.1. HIV
      • 7.1.2.2. hepatitis
      • 7.1.2.3. influenza
    • 7.1.3. Bacterial diseases
      • 7.1.3.1. tuberculosis
      • 7.1.3.2. MRSA
    • 7.1.4. Fungal infections
      • 7.1.4.1. candidiasis
    • 7.1.5. Parasitic infections
    • 7.1.6. Others

8. PCR-based Infectious Diseases Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical diagnostics
    • 8.1.3. Research applications
    • 8.1.4. Epidemiological studies

9. PCR-based Infectious Diseases Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Pharmaceutical & Biotechnology Companies

10. PCR-based Infectious Diseases Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Traditional PCR
    • 10.1.3. Real-time PCR (qPCR)
    • 10.1.4. Digital PCR (dPCR)
    • 10.1.5. Reverse Transcriptase PCR (RT-PCR)
    • 10.1.6. Nested PCR
    • 10.1.7. Multiplex PCR

11. PCR-based Infectious Diseases Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. PCR-based Infectious Diseases Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. PCR-based Infectious Diseases Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. PCR-based Infectious Diseases Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. PCR-based Infectious Diseases Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. PCR-based Infectious Diseases Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- PCR-based Infectious Diseases Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Takara Bio, Inc
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. Qiagen N.V.
    • 12.2.5. Bio-Rad Laboratories, Inc
    • 12.2.6. Roche Diagnostics
    • 12.2.7. Cepheid
    • 12.2.8. DiaSorin
    • 12.2.9. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PCR-based Infectious Diseases Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global PCR-based Infectious Diseases Market, by Disease Type 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PCR-based Infectious Diseases Market, by Application 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global PCR-based Infectious Diseases Market, by End User 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global PCR-based Infectious Diseases Market, by Technology 2019-2032 (USD Million)
  • TABLE PCR-based Infectious Diseases Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PCR-based Infectious Diseases Market, by Region 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE North America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)